POLD1 and cancer: In the mice model, when the exonuclease domain of Pol δ (encoded by the POLD1 gene) or Pol ɛ (encoded by the POLE gene) was inactivated by mutation at exonuclease, catalytic residue elevated base substitution mutation rates, and increased incidence of cancers was observed.